BRAF (+) | BRAF (−) | p value** | |
---|---|---|---|
Age, mean ± SD* | 60.67 ± 15.81 | 60.67 ± 13.49 | 1.000 |
Age category, n (%) | |||
< 65 years | 13 (33.33) | 10 (25.64) | 0.469 |
≥ 65 years | 8 (20.51) | 8 (20.51) | |
Sex, n (%) | |||
Male | 8 (20.51) | 9 (23.08) | 0.336 |
Female | 13 (33.33) | 9 (23.08) | |
Anatomic location, n (%) | |||
Extremity | 14 (35.90) | 15 (38.46) | 0.207 |
Central | 7 (17.95) | 3 (7.69) | |
Lymph node metastasis, n (%) | |||
Present | 10 (25.64) | 8 (20.51) | 0.549 |
Absent | 11 (28.21) | 10 (25.64) | |
Tumor thickness, n (%) | |||
≤ 4 mm | 1 (2.56) | 3 (7.69) | 0.246 |
> 4 mm | 20 (51.28) | 15 (38.46) | |
Ulceration, n (%) | |||
Present | 10 (25.64) | 12 (30.77) | 0.192 |
Absent | 11 (28.21) | 6 (15.38) | |
Mitotic index, mean ± SD* | 25.82 ± 18.77 | 23.22 ± 16.08 | 0.648 |
Mitotic index category, n (%) | |||
≥ 20% | 12 (30.77) | 10 (25.64) | 0.588 |
< 20% | 9 (23.08) | 8 (20.51) | |
Necrosis, n (%) | |||
Present | 17 (43.59) | 11 (28.21) | 0.570 |
Absent | 4 (10.26) | 7 (17.95) | |
Lymphovascular invasion, n (%) | |||
Present | 9 (23.08) | 4 (10.26) | 0.153 |
Absent | 12 (30.77) | 14 (35.90) | |
Tumor-infiltrating lymphocytes, n (%) | |||
Present | 13 (33.33) | 13 (33.33) | 0.368 |
Absent | 8 (20.51) | 5 (12.82) |